Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03124550 · ClinicalTrials.gov registry record · NA
Development of An Exergame for Caregivers of Individuals With Alzheimer's Disease or Related Dementias
A NA study, sponsored by Brandeis University.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT03124550: Completed NA study, sponsored by Brandeis University.
NCT03124550 is a NA study that has completed, run by Brandeis University. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03124550, a NA study, has completed, sponsored by Brandeis University.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The study goal is to evaluate user experience with our developed exergame, which was designed to increase physical activity, exercise self-efficacy, and social connections among caregivers of individuals with Alzheimer's disease (AD) or related dementias. Participants will use this garden-themed exergame for six weeks. Tailoring an exergame for caregivers of AD or related dementias has the potential to increase physical activity and to improve overall health and well-being in this vulnerable population, which in turn can benefit the patients for whom they provide care. All study sessions be held at a location convenient to participants.
Primary Outcome
Number of steps recorded daily from the Fitbit, weekly step averages
Interventions
- BEHAVIORAL Exergame Experience
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2017-05-11 |
| Est. Completion | 2019-09-20 |
| Phase | NA |
What the finished NCT03124550 record still lists
NCT03124550 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Exergame Experience is the first listed.
NCT03124550 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03124550 about?
NCT03124550 is a clinical study titled "Development of An Exergame for Caregivers of Individuals With Alzheimer's Disease or Related Dementias". The study goal is to evaluate user experience with our developed exergame, which was designed to increase physical activity, exercise self-efficacy, and social connections among caregivers of individuals with Alzheimer's disease (AD) or related dementias. Participants will use this garden-themed exe...
What is the current status of trial NCT03124550?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2017-05-11. Estimated completion is 2019-09-20.
What interventions are being tested in trial NCT03124550?
The interventions under investigation include: Exergame Experience (BEHAVIORAL).
Who is sponsoring clinical trial NCT03124550?
This trial is sponsored by Brandeis University, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03124550's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI